On the mechanisms of photodynamic action of photosensitizers based on polycationic derivatives of synthetic bacteriochlorin against human lung cancer cells A549 (in vitro study)

Photodiagnosis Photodyn Ther. 2022 Sep:39:102955. doi: 10.1016/j.pdpdt.2022.102955. Epub 2022 Jun 8.

Abstract

Background: One of the tasks of anticancer photodynamic therapy is increasing the efficacy of treatment of cancer nodes with large (clinically relevant) sizes using near-infrared photosensitizers (PS). We study the photodynamic action against A549 human lung cancer cells using PS based on polycationic derivatives of synthetic bacteriochlorin.

Methods: The efficacy and mechanisms of the photodynamic action of PS based on polycationic derivatives of synthetic bacteriochlorin against A549 lung cancer cells were studied in vitro using immunocytochemical and morphological methods.

Results: It was found that PS based on tetracationic and octacationic derivatives of synthetic bacteriochlorin induce necrosis, apoptosis, decreasing of proliferative and mitotic activity, as well as reducing the number of ALDH1-positive cancer cells with signs of stem cells in A549 human lung cancer cell culture. The IC50 values (concentration of a PS that reduces cells survival by 50%) were about 0.69 μM for tetracationic PS and 0.57 μM for octacationic PS under irradiation at 30 J/cm2 while in the "dark" control they were higher than 100 μM for both PSs.

Conclusions: Photosensitizers based on polycationic derivatives of synthetic bacteriochlorin have high phototoxicity against A549 cancer cells caused by the induction of necrosis and apoptosis of cancer cells, including cells with signs of stemness, and a sharp decrease of mitotic and proliferative activity.

Keywords: ALDH1-positive lung cancer stem cells; Apoptosis; Bacteriochlorin; Cationic; Mitosis; Necrosis; Photodynamic therapy; Photosensitizer.

MeSH terms

  • Humans
  • Lung Neoplasms* / drug therapy
  • Necrosis / drug therapy
  • Photochemotherapy* / methods
  • Photosensitizing Agents / pharmacology
  • Photosensitizing Agents / therapeutic use
  • Porphyrins* / pharmacology

Substances

  • Photosensitizing Agents
  • Porphyrins
  • bacteriochlorin